Woodside Energy Group Ltd
WDS
ANZ Group Holdings Ltd
ANZ
CommBank
CBA
4
Origin Energy Ltd
ORG
5
Westpac Banking Corp
WBC
AU Stock MarketDetailed Quotes
PER Percheron Therapeutics Ltd
- 0.014
- +0.002+16.67%
20min DelayTrading Feb 26 12:57 AET
15.22MMarket Cap-1.00P/E (Static)
0.015High0.012Low4.01MVolume0.012Open0.012Pre Close56.22KTurnover0.14052wk High0.51%Turnover Ratio1.09BShares0.00552wk Low-0.014EPS TTM10.97MFloat Cap0.140Historical HighLossP/E (Static)783.55MShs Float0.005Historical Low-0.014EPS LYR25.00%Amplitude--Dividend TTM1.00P/B1Lot Size--Div YieldTTM
About Percheron Therapeutics Ltd Company
Percheron Therapeutics Ltd is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The company operates into two operating segment: ATL1102 and ATL1103. Key revenue is generated from ATL1102.
Company Profile
SymbolPER
Company NamePercheron Therapeutics Ltd
Founded2000
MarketASX
Employees3
Fiscal Year Ends06-30
Address14 Wallace Avenue LEVEL 1
CityToorak
CountryAustralia
Zip Code3142
Phone+61 398278999
Websitehttps://www.percherontx.com
Share RegistryBOARDROOM PTY LIMITED
LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
(02) 9290 9600
Company Executives
- Name
- Position
- Salary
- James Garner
- Chief Executive Officer,Managing Director
- --
- Charmaine Gittleson
- Executive Chairman,Executive Director
- --
- Ben Gil Price
- Non-Executive Director
- --